BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2014 2:06:00 PM | Browse: 1238 | Download: 1076
Publication Name World Journal of Clinical Oncology
Manuscript ID 8352
Country Japan
Received
2013-12-26 16:00
Peer-Review Started
2013-12-27 09:38
To Make the First Decision
2014-01-08 14:03
Return for Revision
2014-01-17 11:40
Revised
2014-01-23 10:01
Second Decision
2014-06-18 15:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-18 15:29
Articles in Press
2014-06-18 15:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-24 14:16
Publish the Manuscript Online
2014-12-11 14:23
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer
Manuscript Source Invited Manuscript
All Author List Tokujiro Yano, Tatsuro Okamoto, Seiichi Fukuyama and Yoshihiko Maehara
Funding Agency and Grant Number
Corresponding Author Tokujiro Yano, MD at the Department of Thoracic Surgery, National Hospital Organization Beppu Medical Center, 1473 Uchikamado, Beppu, 874-0011, Japan. e-mail: tokujiro@beppu.hosp.go.jp
Key Words Non-small cell lung cancer; Postoperative recurrence; Distant metastasis; Oligometastases; Local treatment; Locoregional recurrence
Core Tip The postrecurrence survival in non-small cell lung cancer (NSCLC) is considered to largely depend on both the mode of first recurrence (distant, locoregional or combined) and the treatment modality. Therefore, the therapeutic strategy for treating postoperative recurrence in patients with NSCLC should be considered according to the mode of first recurrence. In this way, proper treatment specific to the mode of recurrence will be developed and improvements of the postrecurrence survival can be obtained.
Publish Date 2014-12-11 14:23
Citation Yano T, Okamoto T, Fukuyama S, Maehara Y. Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer. World J Clin Oncol 2014; 5(5): 1048-1054
URL http://www.wjgnet.com/2218-4333/full/v5/i5/1048.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i5.1048
Full Article (PDF) WJCO-5-1048.pdf
Full Article (Word) WJCO-5-1048.doc
Manuscript File 8352-Review.docx
Answering Reviewers 8352-Answering reviewers.pdf
Copyright License Agreement 8352-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 8352-Language certificate.pdf
Peer-review Report 8352-Peer reviews.pdf
Scientific Misconduct Check 8352-CrossCheck.jpg
Scientific Editor Work List 8352-Scientific editor work list.pdf